Modus Therapeutics is member of recently formed SCD Coalition

In early September, the Sickle Cell Disease Coalition (SCDC) was formed to amplify the voice of the sickle cell disease (SCD) stakeholder community to improve outcomes for individuals with SCD. Its membership includes public health, research, provider organizations, patient groups, faith-based organizations, federal agencies, industry representatives, and foundations. Modus Therapeutics has joined as a member of the coalition to show our dedication to SCD.

Find Out More